Low-dose OKT3 treatment for rejection/induction in kidney and kidney- pancreas transplantation

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1552-1554

  Desai, D M ^a   Scandling, J D ^a   Knoppel, C ^a   Dafoe, D C ^a   Alfrey, E J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; ANTIBODY RESPONSE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; INTERNALIZATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; CALIFORNIA; COSTS AND COST ANALYSIS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 0031831162     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00354-6     Document Type: Conference Paper

References (6)

1. Pattison JM, Krensky AM: Am J Med Sci 313:257, 1997
2. Ortho Multicenter Transplant Study Group: N Engl J Med 313:337, 1985
3. Kung P, Goldstein G, Reinherz EL, et al: Science 206:347, 1979
4. Abramowicz D, Schandene L, Goldman M, et al: Transplantation 47:606, 1989
5. Norman DJ, Barry JM, Bennett WM, et al: Transplant Proc 23:1052, 1991
6. Norman DJ, Kimball JA, Barry JM: Transplant Proc 25:35, 1993